Nano-biopolymer high-dilution disinfectant for surface cleaning
Ariviya's nano-biopolymer disinfectant eliminates superbugs at 1:500 dilution with >99.99% kill rate in 15-30 seconds. Eco-friendly, biodegradable, and validated against multiple pathogens for surface hygiene across healthcare, dairy, and consumer markets.
Overview
Ariviya's nano-biopolymer disinfectant addresses the global challenge of microbial biofilm formation on living and non-living surfaces, which causes infections and significant economic losses. The product uses a proprietary bioprocess method to stabilize nanoparticles on biopolymers, creating a scalable, broad-spectrum disinfectant that remains effective even at high dilutions of 1:500. It is eco-friendly and biodegradable, offering a safer alternative to traditional chemical-heavy cleaning products for industries such as healthcare, dairy, veterinary care, and consumer hygiene.
Technical specifications
Key features:
- Broad-spectrum efficacy: kills superbugs and multiple bacterial pathogens including Staphylococcus aureus, E. coli, Salmonella, Streptococcus agalactiae, Clostridium spp., Citrobacter spp., Corynebacterium spp., and Enterobacter spp.
- High dilution performance: achieves >99.99% reduction (4 log10) within 15-30 seconds of exposure even at 1:500 dilution
- Validated methodology: tested using AOAC 960.09 and EN1276 protocols following EPA guidelines
- Long-term stability: tested for 110 days at 10-day intervals, demonstrating consistent zone of clearance and stable shelf-life performance
- Eco-friendly composition: biodegradable nano-biopolymer platform with natural antimicrobial properties
- Platform technology: adaptable base formulation applicable to multiple disinfection use cases
Technology readiness level
The disinfectant has been validated in India using EPA-aligned AOAC 960.09 and EN1276 methodologies, demonstrating >99.99% efficacy against key pathogens. Stability testing over 110 days confirmed product consistency and shelf-life performance. Future validation plans include safety and efficacy testing at GLP-certified laboratories to meet EPA regulatory requirements for product approval, with additional plans to satisfy regulatory agencies across different geographies for global market entry. The underlying nano-biopolymer platform technology is positioned for expansion into additional applications and product lines.
About Ariviya, Inc
Ariviya is a deep tech startup that develops innovative solutions for wound care, pathogen detection, and surface disinfection by leveraging nano biopolymer technology. The company utilizes a proprietary process to stabilize nanoparticles on biopolymers, creating scalable products for human and veterinary applications. Its technology portfolio includes nano-based biosensors for detecting bacteria and viruses, natural antimicrobial polymers, and advanced wound management solutions. By focusing on science-based interventions, Ariviya provides alternatives to traditional chemical-heavy products, aiming to improve hygiene and health outcomes across various industries, including dairy, healthcare, and pet care.
The company’s solutions address critical challenges such as mastitis in dairy cattle, environmental hygiene, and infection management. Its product line features items like AnimaSpray for wound healing, MammaryO for natural teat care, and various surface disinfectants like Cleanida and PetEnviron. Through its research and development efforts, Ariviya seeks to provide safer, more effective options for individuals, families, and animals. The company operates through strategic partnerships, incubators, and laboratories in India and the United States, positioning itself as a science-driven provider of therapeutics and health-maintenance technologies for both clinical and consumer markets.
Inquire about this partnering listing
Looking for
Industry applications
delivered to your inbox.